Our Team

April has broad experience in leading global research and development teams with a strong background in Regulatory Affairs and experience in early-stage startups in the 20+ years of drug research and development positions. April holds a bachelor’s degree in General Biology and a Master’s Degree in Quality Assurance and Regulatory Affairs, with certifications in clinical trial management and project management. April started her career at Parke-Davis in global regulatory submissions and worked on the electronic submissions team for Lyrica. In 2003, April started working in project management at Esperion Therapeutics and through the Pfizer acquisition of Esperion. In 2008, April joined the second iteration of Esperion as the Director of Project Management that led to the successful development and approval of bempedoic acid in the US and EU. As part of the bempedoic acid global team, she managed the program from data and material acquisition from Pfizer, initial Quality and Regulatory oversight, working with and at times part of the Esperion Leadership team, Document Management and Archive (including Part 11) systems user management and oversight, internal FDA contact and communications, NDA Team Lead, part of the bempedoic acid IND, EOP2, Phase 3 and CVOT teams, business development and out-license due diligence teams, and many other leadership responsibilities over the 20+ years working in Pharmaceutical R&D.